SEC Form 4 · accession 0001209191-18-037481
SURMODICS INC · SRDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles W Olson
Officer — Senior VP of Bus Dev, Med Dev
Period of report
Jun 11, 2018
Accepted (ET)
Jun 13, 2018 · 4:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000924717
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 11, 2018 | M | 4,280 | $23.95 | A | 39,955 | D | |
| Common Stock | Jun 11, 2018 | M | 9,963 | $20.25 | A | 49,918 | D | |
| Common Stock | Jun 11, 2018 | F | 9,484 | $55.40 | D | 40,434 | D | |
| Common StockF3 | Jun 11, 2018 | S | 10,000 | $55.002 | D | 30,434 | D | |
| Common Stock | holding | — | — | — | 800 | I | By IRA |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F4 | $23.95 | Jun 11, 2018 | M | 4,280 | D | — | Nov 30, 2023 | Common Stock | 4,280 | 12,841 | D |
| Employee Stock Option (right to buy)F5 | $20.25 | Jun 11, 2018 | M | 9,963 | D | — | Dec 17, 2022 | Common Stock | 9,963 | 9,964 | D |
Explanation of responses
- F1The reporting person makes a payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3.
- F2Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2018.
- F3Reflects the weighted average price of 10,000 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on June 11, 2018 with sale prices ranging from $55.00 to $55.05 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4The award vests in four equal installments on each of the first four anniversaries of the November 30, 2016 grant date.
- F5The award vests in four equal installments on each of the first four anniversaries of the December 17, 2015 grant date.